Drug Master Files for: hydroxypropyl cellulose
✉ Email this page to a colleague
hydroxypropyl cellulose Drug Master Files
DMF No. | Status | Type | Submission Date | Holder | Subject |
---|---|---|---|---|---|
10772 | I | IV | 3/10/1994 | WACKER CHEMICAL CORP | HYDROXYPROPYL BETA CYCLODEXTRIN (HPBCD) |
12266 | I | IV | 12/3/1996 | JANSSEN BIOTECH NV | HYDROXYPROPYL-BETA-CYCLODEXTRIN, (ENCAPSIN HPB) |
12482 | I | IV | 4/10/1997 | CERESTAR USA INC | HYDROXYPROPYL BETA CYCLODEXTRIN |
12681 | I | III | 9/30/1997 | 3M PHARMACEUTICALS | NON-CLINICAL PHARMACOLOGY TOXICOLOGY STUDIES ON HYDROXYPROPYL-BETA-CYCLODEXTRIN (ENCAPSIN HPB) |
>DMF No. | >Status | >Type | >Submission Date | >Holder | >Subject |
Drug Master File Glossary
STATUS OF DMFS
- A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
- I = Inactive
- N = Not an assigned number
- P = DMF Pending Filing Review
TYPES OF DMFs
- Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
- Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
- Type III Packaging Material
- Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
- Type V FDA Accepted Reference Information